摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-3-氧代丁基乙酸酯 | 648432-76-2

中文名称
2-氯-3-氧代丁基乙酸酯
中文别名
——
英文名称
2-Chloro-3-oxobutyl acetate
英文别名
(2-chloro-3-oxobutyl) acetate
2-氯-3-氧代丁基乙酸酯化学式
CAS
648432-76-2
化学式
C6H9ClO3
mdl
——
分子量
164.59
InChiKey
WBOOXIGZTABOGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    10
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Thiazole-based Nitric Oxide donors having Acyl substuent(s) and uses thereof
    申请人:Assaf Peter
    公开号:US20080233163A1
    公开(公告)日:2008-09-25
    Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of tolerance to the compounds upon repetitive administration is prevented or decreased. Also disclosed are methods of preparing such NO-donating compounds, pharmaceutical compositions and medical devices containing such compounds and methods utilizing such compounds in the treatment of various medical conditions.
    本发明涉及新型NO供体化合物,其设计使得当NO从化合物中释放时,会形成一种天然代谢产物残留物,从而预防或减少重复给药时对化合物的耐受性发展。同时,本发明还涉及制备这种NO供体化合物的方法,包含这种化合物的制药组合物和医疗器械以及利用这种化合物治疗各种医学状况的方法。
  • Nitric oxide donors and uses thereof
    申请人:Assaf Peter
    公开号:US20070021382A1
    公开(公告)日:2007-01-25
    Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of tolerance to the compounds upon repetitive administration is prevented or decreased. Also disclosed are methods of preparing such NO-donating compounds, pharmaceutical compositions and medical devices containing such compounds and methods utilizing such compounds in the treatment of various medical conditions.
    本发明涉及一种新型的NO供体化合物,其设计是当NO从化合物中释放时,会形成一种天然代谢物残留物,从而防止或减少反复给药时对该化合物的耐受性发展。此外,本发明还涉及制备这种NO供体化合物的方法,包含这种化合物的药物组合物和医疗器械,以及利用这些化合物治疗各种医疗状况的方法。
  • US7189750B2
    申请人:——
    公开号:US7189750B2
    公开(公告)日:2007-03-13
  • US7332513B2
    申请人:——
    公开号:US7332513B2
    公开(公告)日:2008-02-19
  • US7368577B2
    申请人:——
    公开号:US7368577B2
    公开(公告)日:2008-05-06
查看更多